UB Paderborn / Katalog / Suche / in CDI

1 – 12 von 12

Sortiert nach

Phase III, Randomized Study of Gemcitabine and Oxaliplatin Versus Gemcitabine (fixed-dose rate infusion) Compared With Gemcitabine (30-minute infusion) in Patients With Pancreatic Carcinoma E6201: A Trial of the Eastern Cooperative Oncology Group

Journal of clinical oncology, 2009-08, Vol.27 (23), p.3778-3785

2009

Link zum Volltext

Verfügbarkeit prüfen

Phase I Trial of the Antivascular Agent Combretastatin A4 Phosphate on a 5-Day Schedule to Patients With Cancer: Magnetic Resonance Imaging Evidence for Altered Tumor Blood Flow

Journal of clinical oncology, 2003-12, Vol.21 (23), p.4428-4438

2003

Link zum Volltext

Verfügbarkeit prüfen

Pathological Fracture and Prognosis of High-Grade Osteosarcoma of the Extremities: An Analysis of 2,847 Consecutive Cooperative Osteosarcoma Study Group (COSS) Patients

Journal of clinical oncology, 2020-03, Vol.38 (8), p.823-833

2020

Link zum Volltext

Verfügbarkeit prüfen

Fluorouracil Modulation in Colorectal Cancer: Lack of Improvement With N -Phosphonoacetyl- l -Aspartic Acid or Oral Leucovorin or Interferon, But Enhanced Therapeutic Index With Weekly 24-Hour Infusion Schedule—An Eastern Cooperative Oncology Group/Cancer and Leukemia Group B Study

Journal of clinical oncology, 2001-05, Vol.19 (9), p.2413-2421

2001

Link zum Volltext

Verfügbarkeit prüfen

PET-directed combined modality therapy for gastroesophageal junction cancer: First results of the prospective MEMORI trial

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.4018-4018

2019

Link zum Volltext

Verfügbarkeit prüfen

Priorities in Colorectal Cancer Research: Recommendations From the Gastrointestinal Scientific Leadership Council of the Coalition of Cancer Cooperative Groups

Journal of clinical oncology, 2007-06, Vol.25 (16), p.2313-2321

2007

Link zum Volltext

Verfügbarkeit prüfen

Phase I Clinical and Pharmacogenetic Trial of Irinotecan and Raltitrexed Administered Every 21 Days to Patients With Cancer

Journal of clinical oncology, 2001-10, Vol.19 (20), p.4081-4087

2001

Link zum Volltext

Verfügbarkeit prüfen

Impact of age on the feasibility and efficacy of neoadjuvant chemotherapy in patients with locally advanced gastroesophageal cancer: A retrospective pooled analysis of individual patient data

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.4063-4063

2014

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of toremifene in patients with advanced cancer

Journal of clinical oncology, 1991-11, Vol.9 (11), p.2036-2041

1991

Link zum Volltext

Verfügbarkeit prüfen

Phase I Study of Toremifene in Patients With Advanced Cancer

Journal of clinical oncology, 1992-04, Vol.10 (4), p.674-674

1992

Link zum Volltext

Verfügbarkeit prüfen

1 – 12 von 12

Suche als RSS-Feed

Aktive Filter

PublikationsformBücher

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(12)
Mit Volltextzugriff
(12)

Publikationsform

Artikel
(12)

Sprache

Englisch
(12)
Japanisch
(1)

Erscheinungsjahr

n.n

Kollektion

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase III, Randomized Study of Gemcitabine and Oxaliplatin Versus Gemcitabine (fixed-dose rate infusion) Compared With Gemcitabine (30-minute infusion) in Patients With Pancreatic Carcinoma E6201: A Trial of the Eastern Cooperative Oncology Group

Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance)

Phase I Trial of the Antivascular Agent Combretastatin A4 Phosphate on a 5-Day Schedule to Patients With Cancer: Magnetic Resonance Imaging Evidence for Altered Tumor Blood Flow

Pathological Fracture and Prognosis of High-Grade Osteosarcoma of the Extremities: An Analysis of 2,847 Consecutive Cooperative Osteosarcoma Study Group (COSS) Patients

Fluorouracil Modulation in Colorectal Cancer: Lack of Improvement With N -Phosphonoacetyl- l -Aspartic Acid or Oral Leucovorin or Interferon, But Enhanced Therapeutic Index With Weekly 24-Hour Infusion Schedule—An Eastern Cooperative Oncology Group/Cancer and Leukemia Group B Study

PET-directed combined modality therapy for gastroesophageal junction cancer: First results of the prospective MEMORI trial

Priorities in Colorectal Cancer Research: Recommendations From the Gastrointestinal Scientific Leadership Council of the Coalition of Cancer Cooperative Groups

Phase I Clinical and Pharmacogenetic Trial of Irinotecan and Raltitrexed Administered Every 21 Days to Patients With Cancer

Impact of age on the feasibility and efficacy of neoadjuvant chemotherapy in patients with locally advanced gastroesophageal cancer: A retrospective pooled analysis of individual patient data

Intergroup randomized phase III study of postoperative oxaliplatin, 5-fluorouracil and leucovorin (mFOLFOX6) vs mFOLFOX6 and bevacizumab (Bev) for patients (pts) with stage II/ III rectal cancer receiving pre-operative chemoradiation

Phase I study of toremifene in patients with advanced cancer

Phase I Study of Toremifene in Patients With Advanced Cancer

Aktive Filter

Suchergebnisse filtern